CH674363A5 - - Google Patents

Download PDF

Info

Publication number
CH674363A5
CH674363A5 CH4345/87A CH434587A CH674363A5 CH 674363 A5 CH674363 A5 CH 674363A5 CH 4345/87 A CH4345/87 A CH 4345/87A CH 434587 A CH434587 A CH 434587A CH 674363 A5 CH674363 A5 CH 674363A5
Authority
CH
Switzerland
Prior art keywords
formula
compounds
compound
compounds according
salts
Prior art date
Application number
CH4345/87A
Other languages
German (de)
English (en)
Inventor
George William Holland
Hans Maag
Perry Rosen
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of CH674363A5 publication Critical patent/CH674363A5/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • C07D307/937Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans with hydrocarbon or substituted hydrocarbon radicals directly attached in position 2, e.g. prostacyclins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
CH4345/87A 1986-12-01 1987-11-06 CH674363A5 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US93652286A 1986-12-01 1986-12-01

Publications (1)

Publication Number Publication Date
CH674363A5 true CH674363A5 (es) 1990-05-31

Family

ID=25468757

Family Applications (1)

Application Number Title Priority Date Filing Date
CH4345/87A CH674363A5 (es) 1986-12-01 1987-11-06

Country Status (14)

Country Link
JP (1) JPS63145275A (es)
AT (1) AT391697B (es)
AU (1) AU597128B2 (es)
BE (1) BE1001271A5 (es)
CH (1) CH674363A5 (es)
DE (1) DE3740595A1 (es)
DK (1) DK627787A (es)
FR (1) FR2607501A1 (es)
GB (1) GB2198130B (es)
IT (1) IT1223390B (es)
NL (1) NL8702855A (es)
NZ (1) NZ222723A (es)
SE (1) SE8704770L (es)
ZA (1) ZA878947B (es)

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2088856B (en) * 1980-10-27 1984-06-27 Chinoin Gyogyszer Es Vegyeszet 7-substituted pg12-derivatives their preparation and pharmaceutical compositions containing them
DE3176313D1 (en) * 1980-12-09 1987-08-20 Teijin Ltd Novel halogenated prostacyclins, process for the production thereof, and pharmaceutical use thereof
US4558142A (en) * 1981-03-11 1985-12-10 Hoffmann-La Roche Inc. 7-Fluoro-prostacyclin analogs
CH651033A5 (de) * 1981-03-11 1985-08-30 Hoffmann La Roche Fluorprostacycline.
JPS5867682A (ja) * 1981-10-16 1983-04-22 Teijin Ltd フルオロpgi↓2類の製法
JPS58150583A (ja) * 1982-03-04 1983-09-07 Teijin Ltd 新規なハロゲン化プロスタサイクリン類、それらの製造法およびそれらを活性成分とする薬学的組成物
JPS59227888A (ja) * 1983-06-10 1984-12-21 Asahi Glass Co Ltd 7−フルオロプロスタグランジン類の製造方法
US4634782A (en) * 1985-06-24 1987-01-06 Hoffmann-La Roche Inc. 7-fluoro-dihydro PGI compounds

Also Published As

Publication number Publication date
ATA313887A (de) 1990-05-15
FR2607501A1 (fr) 1988-06-03
DK627787D0 (da) 1987-11-30
IT8722814A0 (it) 1987-11-30
GB8727991D0 (en) 1988-01-06
IT1223390B (it) 1990-09-19
SE8704770D0 (sv) 1987-11-30
GB2198130B (en) 1990-08-08
NL8702855A (nl) 1988-07-01
ZA878947B (en) 1988-06-01
DK627787A (da) 1988-06-02
BE1001271A5 (fr) 1989-09-12
AU597128B2 (en) 1990-05-24
GB2198130A (en) 1988-06-08
AU8190787A (en) 1988-06-02
DE3740595A1 (de) 1988-06-16
NZ222723A (en) 1990-11-27
AT391697B (de) 1990-11-12
SE8704770L (sv) 1988-06-02
JPS63145275A (ja) 1988-06-17

Similar Documents

Publication Publication Date Title
DD158773A5 (de) Verfahren zur herstellung neuer glycerol-deri vate
AT394362B (de) Verfahren zur herstellung von neuen 2,6-disubstituierten naphthalin-derivaten
CH664150A5 (de) Fumarsaeureprodrug, verfahren zu seiner herstellung und dieses enthaltende darreichungsformen.
DE3536669A1 (de) Zusammensetzung fuer die perkutane verabreichung von medikamenten und verfahren zur foerderung der perkutanen absorption von medikamenten
DE2549783A1 (de) Triglyceride mit entzuendungshemmender wirkung
EP0369263A2 (de) Präparate zur topischen Behandlung von Hautkrankheiten
DE2947624A1 (de) Beta, gamma -dihydropolyprenylalkohol und diesen enthaltendes blutdrucksenkendes arzneimittel
DE3821317A1 (de) Thioharnstoffderivate
EP0132811A1 (de) In 1-Stellung substituierte 4-Hydroxymethyl-pyrrolidinone, Verfahren zu ihrer Herstellung, pharmazeutische Zusammensetzungen und Zwischenprodukte
EP0009777B1 (de) Retinsäure- und 7,8-Dehydro-retinsäure-N-(carboxy)-phenyl-amide, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Mittel
EP0656889B1 (de) 9-chlor-prostaglandin-ester und -amide und ihre verwendung für die herstellung von arzneimitteln
AT391697B (de) Neue prostacycline
DE3313778A1 (de) N-carbamoyl-(5,4b)-isothiazolopyridin-3-on-derivate, verfahren zu ihrer herstellung und anti-aknemittel, die diese verbindung enthalten
DE1926359A1 (de) oxylkansaeuren
DE2434929A1 (de) Acetaminophenester von arylsalicylsaeuren
CH627761A5 (en) Process for the preparation of 17 beta esters of testosterone and 5 alpha-dihydrotestosterone
DE3642247A1 (de) Mono-, di- und tri-ester von 1,8-dihydroxy-10-phenyl-9-anthron oder 9-anthranol, verfahren zu ihrer herstellung und ihre verwendung in der human- oder veterinaermedizin sowie als kosmetikum
JPH06500778A (ja) 局所治療および組成物
WO1994006748A1 (de) Neue in 10-stellung substituierte anthron- und anthracen-derivate, verfahren zu deren herstellung, diese verbindungen enthaltende pharmazeutische oder kosmetische mittel und deren verwendung
EP0498011B1 (de) Neue Salze der 2-(2,6-Dichloranilino)-phenylessigsäure, Verfahren zu ihrer Herstellung und ihre Verwendung für topisch anwendbare pharmazeutische Zubereitungen
DE2260743C3 (de) 2,6,6-Trimethyl-1-(10'-carboxydeca-1',3',5',7',9'-pentaenyl)-cyclohex-1-en und 2,6,6-Trimethyl-1-(12' - carboxydodeca-1',3',5',7',9',11'-hexanyl)-cyclohex-1-en, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Mittel
DE2141357C3 (de) Bis-(4-chlorphenoxy)-essigsäureester, Verfahren zu ihrer Herstellung diese Verbindungen enthaltende Arzneimittel
EP0010209B1 (de) N-Benzoyl-retinylamine, Verfahren zu ihrer Herstellung, diese enthaltende pharmazeutische Mittel und die Verwendung dieser Verbindungen bei der Therapie und Prophylaxe von Praekanzerosen und Karzinomen der Haut
AT353272B (de) Verfahren zur herstellung von neuen piperidin- derivaten sowie von deren salzen und optisch aktiven formen
CH639109A5 (de) A-nor-androsta-3(5),16-dien-2-on- und a-nor-androsta-3(5),6,16-trien-2-on-derivate.

Legal Events

Date Code Title Description
PL Patent ceased